Abstract
Importance In the United States, schools closed in March 2020 to reduce the burden of COVID-19. They are now reopening amid high incidence in many places, necessitating analyses of the associated risks and benefits.
Objective To determine the impact of school reopening with varying levels of operating capacity and face-mask adherence on COVID-19 burden.
Design Modeling study using an agent-based model that simulates daily activities of the population. Transmission can occur in places such as schools, workplaces, community, and households. Model parameters were calibrated to and validated against multiple types of COVID-19 data.
Setting Indiana, United States of America.
Participants Synthetic population of Indiana. K-12 students, teachers, their families, and others in the state were studied separately.
Interventions Reopening of schools under three levels of school operating capacity (50%, 75%, and 100%), as well as three assumptions about face-mask adherence in schools (50%, 75%, and 100%). We compared the impact of these scenarios to reopening at full capacity without face masks and a scenario with schools operating remotely, for a total of 11 scenarios.
Main outcomes SARS-CoV-2 infections, symptomatic cases, and deaths due to COVID-19 from August 24 to December 31.
Results We projected 19,527 (95% CrI: 4,641–56,502) infections and 360 (95% CrI: 67–967) deaths in the scenario where schools operated remotely from August 24 to December 31. Reopening at full capacity with low face-mask adherence in schools resulted in a proportional increase of 81.7 (95% CrI: 78.2–85.3) times the number of infections and 13.4 (95% CrI: 12.8–14.0) times the number of deaths. High face-mask adherence resulted in a proportional increase of 3.0 (95% CrI: 2.8–3.1) times the number of infections. Operating at reduced capacity with high face-mask adherence resulted in only an 11.6% (95% CrI: 5.50%-17.9%) increase in the number of infections.
Conclusions and Relevance Reduced capacity and high face-mask adherence in schools would substantially reduce the burden of COVID-19 in schools and across the state. We did not explore the impact of other reopening scenarios, such as alternating days of attendance. Heterogeneous decisions could be made across different districts throughout the state, which our model does not capture. Hence, caution should be taken in interpreting our results as specific quantitative targets for operating capacity or face-mask adherence. Rather, our results suggest that schools should give serious consideration to reducing capacity as much as is feasible and enforcing adherence to wearing face masks.
Question What will be the impact of reopening schools on SARS-CoV-2 infections and COVID-19 mortality in Indiana?
Findings Reopening schools at full capacity with low (50%) face-mask adherence could have a substantial effect on the burden of COVID-19 across Indiana, leading to 83 times more infections and 13 times more deaths than if schools operated remotely. Reopening at 50% capacity and with 100% face-mask adherence could mitigate much of this risk, leading to 12% more infections and 5% more deaths than if schools operated remotely.
Meaning Schools should make efforts to reduce capacity and enforce face-mask adherence to prevent increases in the statewide burden of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by an NSF RAPID grant to TAP (DEB 2027718), an Arthur J. Schmitt Fellowship and Eck Institute for Global Health Fellowship to RJO, and a Richard and Peggy Notabaert Premier Fellowship to MP. We thank the University of Notre Dame Center for Research Computing for computing resources.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a simulation model and does not require IRB approval
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is publicly available
